carbetapentane has been researched along with kainic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Cheon, MA; Jhoo, WK; Kim, HC; Kim, WK; Ko, KH; Shin, CY; Shin, EJ | 1 |
2 other study(ies) available for carbetapentane and kainic acid
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Carbetapentane attenuates kainate-induced seizures via sigma-1 receptor modulation.
Topics: Animals; Benzoxazines; Brain; Cells, Cultured; Cyclopentanes; Drug Interactions; Immunohistochemistry; Kainic Acid; Male; Oxazines; Rats; Rats, Sprague-Dawley; Receptors, sigma; Seizures; Sigma-1 Receptor | 2001 |